Determination of R-(+)-higenamine enantiomer in Nelumbo nucifera by high-performance liquid chromatography with a fluorescent chiral tagging reagent

Microchemical Journal

Volumn 96, Issue 2, 2010, Pages 374-379

  Hong, Haixin ^a   Lee, Yong Ill ^b   Jin, Dongri ^a  

^a YANBIAN UNIVERSITY   (China)

^b Changwon National University   (South Korea)

Author keywords

Derivatization; Diastereomer separation; Fluorescence detection; Higenamine enantiomers; HPLC

Indexed keywords

EID: 80053327780     PISSN: 0026265X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.microc.2010.06.011     Document Type: Article

References (22)

1. Kosuge T., Yokota M. Studies on cardiac principle of aconite root. Chem. Pharm. Bull. 1976, 24:176-178.
2. Kosuge T., Yokota M., Nagasawa M. Studies on cardiac principle in Aconite roots. I. Isolation and structural determination of higenamine. Yakugaku Zasshi 1978, 98:1370-1375.
3. Kosuge T., Yokota M., Nukya H., Gotoh Y., Nagasawa M. Studies on antitussive principles of Asiasari Radix. Chem. Pharm. Bull. 1978, 26:2284-2285.
4. Leboeuf M., Cavé A., Touché A., Provost J., Forgacs P. ISOLEMENT DE L'HIGÉNAMINE A PARTIR DE L'ANNONA SQUAMOSA; INTERET DES RÉSINES ADSORBANTES MACROMOLÉCULAIRES EN CHIMIEVÉGÉTALE EXTRACTIVE. J. Nat. Prod. 1981, 44:53-60.
5. Xu Q., Lin M. Benzylisoquinoline alkaloids from Gnetum parvifolium. J. Nat. Prod. 1999, 62:1025-1027.
6. Koshiyama H., Ohkuma H., Kawaguchi H., Hsu H.Y., Chem Y.P. Isolation of 1-(p-hydroxybenzyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline(demethylcoclaurine), an active alkaloid from Nelumbo nucifera. Chem. Pharm. Bull. 1970, 18:2564-2568.
7. Chong W.S., Lee Y.S., Kang Y.J., Lee D.H., Ryu J.C., Yun-Choi H.S., Chang K.C. Comparison of inodilator effect of higenamine, YS49, YS51, tetrahydroisoquinoline analogs, and dobutamine in the rat. Kor. J. Physiol. Pharmacol. 1998, 2:323-330.
8. Chang K.C., Chong W.S., Lee I.J. Different pharmacological characteristics of structurally similar benzylisoquinoline analogs, papaverine, higenamine, and GS 389, on isolated rat aorta and heart. Can. J. Physiol. Pharmacol. 1994, 72:327-334.
9. Yun-Choi H.S., Pyo M.K., Park K.M., Chang K.C., Lee D.H. Anti-thrombotic effects of higenamine. Planta Med. 2001, 67:619-622.
10. Kang Y.J., Lee Y.S., Lee G.W., Lee D.H., Ryu J.C., Yun-Choi H.S., Chang K.C. Inhibition of activation of nuclear factor κB is responsible for inhibition of inducible nitric oxide synthase expression by higenamine, an active component of aconite root. J. Pharmacol. Exp. Ther. 1999, 291(1):314-320.
11. Lee H.Y., Lee J.S., Kim E.J., Han J.W., Lee H.W., Kang Y.J., Chang K.C. Inhibition of lipopolysaccharide-induced inducible nitric oxide (iNOS) mRNA expression and nitric oxide production by higenamine in murine peritoneal macrophages. Arch. Pharm. Res. 1999, 22(1):55-59.
12. Kang Y.J., Lee G.W., Ku E.B., Lee H.Y., Chang K.C. Inhibition by higenamine of lipopolysaccharide-induced iNOS and mRNA expression and NO production in rat aorta. Korean J. Physiol. Pharmacol. 1997, 1:297-302.
13. Park J.E., Kang Y.J., Park M.K., Lee Y.S., Kim H.J., Seo H.G., Lee J.H., Yun-Choi H.S., Shin J.S., Lee H.W., Ahn S.K., Chang K.C. Enantiomers of higenamine inhibit LPS-induced iNOS in a macrophage cell line and improve the survival of mice with experimental endotoxemia. Int. Immunopharmacol. 2006, 6:226-233.
14. Park S.O., Hong C.Y., Paik S.W., Yun-Choi H.S. Determination of blood concentration of higenamine by high pressure liquid chromatography. Arch Pharmacol. Res. 1987, 10:60-66.
15. Lo C.F., Chen C.M. Determination of higenamine in plasma and urine by highperformance liquid chromatography with electrochemical detection. J. Chromatogr. B 1994, 655:33-39.
16. Lo C.F., Chen C.M. Pharmacokinetics of higenamine in rabbits. Biopharm. Drug Dispos. 1996, 17:791-803.
17. Jin D., Miyahara T., Toyo'oka T. Determination of amino acids labeled with fluorescent chiral reagents, R(-)- and S(+)-4-(3-isothiocyanatopyrrolidin-1-yl)-7-(N,N-dimethylaminosulfonyl)-2, 1, 3-benzoxadiazoles, in biological and food samples by liquid chromatography. Anal. Biochem. 1999, 269:124-132.
18. Jin D., Nagakura K., Miyahara S.T., Toyo'oka T. Total resolution of 17 DL-amino acids labelled with a fluorescent chiral reagent, R(-)-4-(3-isothiocyanatopyrrolidin-1-yl)-7-(N, N-dimethylaminosulfonyl)-2, 1, 3-benzoxadiazole, by high-performance liquid chromatography. J. Chromatogr. A 1998, 822:215-224.
19. Jin D., Toyo'oka T. Indirect resolution of thiol enantiomers by high-performance liquid chromatography with a fluorescent chiral tagging reagent. Analyst 1998, 123:1271-1277.
20. Jin D., Kumar A.P., Song G.C., Lee Y.I. Determination of thyroxine enantiomers in pharmaceutical formulation by high-performance liquid chromatography-mass spectrometry with precolumn derivatization. Microchem. J. 2008, 88:62-66.
21. Jin D., Zhang M.N., Jin S., Lee M.K., Song G.C., Back G., Lee Y.I. Enantioselective resolution of thyroxine hormone by high-performance liquid chromatography utilizing a highly fluorescent chiral tagging reagent. Chirality 2007, 19:625-631.
22. Zhong-yao-dai-ci-dian (Dictionary of Chinese Crude Drugs) 1978, 1806. Shanghai Scientific Technologic Publisher, Shanghai. Chiang Su New Medical College (Ed.).